New fill/finish partnership with BioConnection provides end-to-end drug product development under 1 contract!   Read the press release

1 min read

Video: BIO-Europe 2020 Presentation: AGC Biologics' Capabilities and Introduction to Cell and Gene Therapy

Byron Kneller, VP, Process Development, Seattle and Luca Alberici, General Manager, Milan, present AGC Biologics’ end-to-end CDMO protein expression and cell and gene therapy manufacturing capabilities at BIO-Europe in October, 2020. 


Have any questions on the material or event? We're happy to help – contact us today. You can also learn more about our Center of Excellence for our Cell and Gene Therapy offering by visiting our Milan facility page.

About BIO

Through education, collaboration and advocacy, BIO strives to drive a bio-revolution that cures patients, protects our climate, and nourishes humanity.

As the largest global non-profit biotechnology trade association representing startups to Fortune 500 companies, BIO is proud to host a portfolio of partnering conferences that not only unite and empower biotech innovators and their ecosystem to improve lives but also offer a broad and unbiased venue to seek investment and BD&L opportunities.